# RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty

Study · id `cardio:ct-nct03064126` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03064126](<https://clinicaltrials.gov/study/NCT03064126>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03064126

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

## Technical summary

Registry record NCT03064126. Randomized; single masking; primary purpose treatment. Start 2017-03-02 (actual); primary completion 2019-11-18 (actual). Results posted on 2020-07-15.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 440 participants (enrolled count; ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Started: 2017-03-02 (actual) (ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Primary completion: 2019-11-18 (actual) (ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Completion: 2023-10-25 (actual) (ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Results first posted: 2020-07-15 (ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Countries: United States; Austria; Belgium; Canada; Japan; New Zealand (ClinicalTrials.gov record NCT03064126, source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03064126-2024-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
- Acronym: RANGER II SFA
- Condition: Peripheral Artery Disease
- Condition: Atherosclerosis
- Condition: Artery Diseases, Peripheral
- Condition: Plaque, Atherosclerotic
- Condition: Occlusive Arterial Disease
- Intervention (Device): RANGER™ Paclitaxel Coated Balloon
- Intervention (Drug): Paclitaxel
- Intervention (Procedure): Standard Balloon Angioplasty
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon (`cardio:pubmed-34016410`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: One-year results for Japanese patients in RANGER II SFA (`cardio:pubmed-34557931`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 66a6f66964dc84b33673843e569a19d7d4953f657850e359cf91815dd867a23d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
